We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+7.14%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.16B
AUM Growth
+$58.2M
Cap. Flow
-$8.77M
Cap. Flow %
-0.75%
Top 10 Hldgs %
38.3%
Holding
252
New
8
Increased
43
Reduced
91
Closed
4

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$4.17M
2
PWR icon
Quanta Services
PWR
+$2.49M
3
ISRG icon
Intuitive Surgical
ISRG
+$2.38M
4
MSFT icon
Microsoft
MSFT
+$1.67M
5
TMUS icon
T-Mobile US
TMUS
+$1.24M

Top Sells

Rank Stock Value
1
BXMT icon
Blackstone Mortgage Trust
BXMT
+$5.47M
2
ABBV icon
AbbVie
ABBV
+$3.2M
3
QCOM icon
Qualcomm
QCOM
+$2.39M
4
DE icon
Deere & Co
DE
+$2.26M
5
DIS icon
Walt Disney
DIS
+$2.25M

Sector Composition

Rank Sector Weight
1 Technology 26.01%
2 Healthcare 19.7%
3 Industrials 12.21%
4 Financials 11.74%
5 Communication Services 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QCOM icon
26
Qualcomm
QCOM
$176B
$11.6M 1%
97,428
-20,752
-18% -$2.39M
HON icon
27
Honeywell
HON
$78B
$11.4M 0.98%
58,057
-302
-0.5% -$56.1K
NSC icon
28
Norfolk Southern
NSC
$75.1B
$11M 0.95%
48,430
-200
-0.4% -$42.5K
J icon
29
Jacobs Solutions
J
$17B
$10.9M 0.94%
111,056
-2,206
-2% -$210K
PEP icon
30
PepsiCo
PEP
$190B
$10.7M 0.92%
57,518
+670
+1% +$125K
CVX icon
31
Chevron
CVX
$366B
$10.3M 0.89%
65,669
-375
-0.6% -$60.1K
BMY icon
32
Bristol-Myers Squibb
BMY
$132B
$10M 0.86%
156,465
-1,125
-0.7% -$75.4K
UNP icon
33
Union Pacific
UNP
$174B
$9.65M 0.83%
47,171
-1,502
-3% -$299K
EMR icon
34
Emerson Electric
EMR
$88.3B
$9.26M 0.8%
102,475
– –
CRM icon
35
Salesforce
CRM
$158B
$8.82M 0.76%
41,763
+4,565
+12% +$932K
AXP icon
36
American Express
AXP
$230B
$8.42M 0.72%
48,349
– –
RTX icon
37
RTX Corp
RTX
$301B
$7.94M 0.68%
81,057
-905
-1% -$88.6K
SHEL icon
38
Shell
SHEL
$245B
$7.73M 0.67%
128,075
+2,450
+2% +$147K
DE icon
39
Deere & Co
DE
$168B
$7.16M 0.62%
17,663
-5,921
-25% -$2.26M
AMZN icon
40
Amazon
AMZN
$2.96T
$6.47M 0.56%
49,626
+4,270
+9% +$488K
ADP icon
41
Automatic Data Processing
ADP
$108B
$6.41M 0.55%
29,150
+175
+0.6% +$37.7K
BP icon
42
BP
BP
$107B
$6.28M 0.54%
178,040
+544
+0.3% +$20.1K
BRK.A icon
43
Berkshire Hathaway Class A
BRK.A
$1.12T
$6.21M 0.53%
12
– –
IBB icon
44
iShares Biotechnology ETF
IBB
$9.77B
$6.09M 0.52%
47,996
– –
CVS icon
45
CVS Health
CVS
$122B
$6.03M 0.52%
87,254
-185
-0.2% -$13.2K
ABT icon
46
Abbott
ABT
$187B
$5.93M 0.51%
54,380
+75
+0.1% +$8K
LLY icon
47
Eli Lilly
LLY
$1.06T
$5.89M 0.51%
12,570
+9,940
+378% +$4.17M
PYPL icon
48
PayPal
PYPL
$50.5B
$5.89M 0.51%
88,207
-360
-0.4% -$24.5K
PFE icon
49
Pfizer
PFE
$153B
$5.72M 0.49%
156,015
-1,515
-1% -$59K
DIS icon
50
Walt Disney
DIS
$181B
$5.7M 0.49%
63,885
-23,737
-27% -$2.25M
1
2
3 4 5

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q2 2023 Portfolio in Review

As of Q2 2023, Neville Rodie & Shaw held 252 positions worth $1.16B, up 5.3% from $1.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4.8%. Neville Rodie & Shaw opened 8 new positions and exited 4, leaving the 252-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

  • Neville Rodie & Shaw's largest Q2 2023 buy was Intuitive Surgical: 7,850 shares worth $2.68M.
  • Neville Rodie & Shaw added most to Eli Lilly in Q2 2023, an estimated $4.17M increase.
  • Neville Rodie & Shaw's biggest Q2 2023 reduction was AbbVie, cutting an estimated $3.2M.
  • Neville Rodie & Shaw fully exited Blackstone Mortgage Trust in Q2 2023, selling an estimated $5.47M.
  • Neville Rodie & Shaw's ten largest holdings make up 38% of its $1.16B portfolio in Q2 2023.
  • Neville Rodie & Shaw opened 8 new positions and closed 4 in Q2 2023.
  • Neville Rodie & Shaw's portfolio value rose 5.3% quarter-over-quarter to $1.16B.

Based on Neville Rodie & Shaw's 13F filing for Q2 2023, filed 6 Jul 2023.